Edward Erickson, Ph.D
Consultant

Dr. Erickson focuses primarily on providing strategic advice on the viability of new pharmaceuticals, and how to bring them to the U.S. market. He offers decades of R&D, business and regulatory experience. After receiving his Ph.D. in Organic Chemistry with an emphasis on Rational Drug Design, Ed began his healthcare career as a medicinal chemist with Riker Laboratories.

After Riker’s acquisition by 3M, Ed progressed through a series of R&D and general management positions – ending his 3M career as Vice President, Drug Delivery Systems. Following retirement, Ed has been active as a consultant and board member with a variety of pharmaceutical start-ups.

Highlights from Ed’s 3M career include managing the drug discovery team which first identified Imiquimod (Aldara) – a novel immune modulator – then as head of global R&D, managing its development and regulatory approval. During this time, he was also responsible for the R&D effort to replace CFC propellants with HFCs in 3M’s pharmaceutical inhalers. Ed then became R&D executive director for 3M’s Life Science Sector, which included managing the hearing health and veterinarian businesses. Next, he became Vice President, Medical-Surgical Division, where he focused on developing infection control products. Later, Ed finished his 3M career with a divisional restructuring effort, separating its drug delivery activities from its ethical pharmaceutical business.

 

Office: (651) 430-7150

Dr. Erickson is not an attorney and does not practice law.

ABOUT THE FIRM
Gardner Law Logo

Gardner Law specializes in laws and regulations that govern the development and commercialization of pharmaceuticals and medical technologies. The firm provides practical and responsive counsel to company leaders navigating the regulatory minefield which they face today.

Proud Member of Medical Alley Association

CONTACT
  • 423 Main Street South
    Stillwater, MN - 55082
  • 612.382.7584
  • 651.430.7150
  • office@gardner.legal
SUBSCRIBE TO NEWS ALERTS